Neurology
4 drugs are in development for Narcolepsy.
- Companies
- 3
- Clinical trials
- 12
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Narcolepsy pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Sunosi | Axsome Therapeutics, Inc. (AXSM) |
Phase 3(2)
Phase 4(1)
| Drug | Company |
|---|---|
| Xywav | Jazz Pharmaceuticals plc (JAZZ) |
About this indication
Narcolepsy context
Neurology·MeSH: Narcolepsy (D009290)
Also known as: Gelineau's Syndromes, Gelineaus Syndrome, Narcoleptic Syndromes, Sleep, Paroxysmal, Syndrome, Gelineau, Syndrome, Narcoleptic
Compare drugs
Frequently asked questions
How many drugs are in development for Narcolepsy?
BioSniper tracks 4 drugs in development for Narcolepsy across 3 companies.
How many clinical trials target Narcolepsy?
There are 12 clinical trials targeting Narcolepsy tracked by BioSniper.